Researcher preparing a microplate for a metabolic receptor assay

Metabolic · Laboratory protocol

Retatrutide

Triple agonist at GLP-1R, GIPR and GCGR. The gGlu-C20 fatty-diacid arm drives albumin binding, which is what separates its kinetics from the native ligands.

For laboratory research use only. Material is supplied as a research reference standard and is not approved by Health Canada. Protocols below are compiled from published literature and supplier documentation; they are reference information, not medical advice. Anyone with a health condition or on medication should speak to a physician first.

Before you begin

• Lot-matched certificate and laboratory notebook
• Calibrated pipettes, low-binding tubes and suitable PPE
• Validated solvent, assay reagents and model-specific SOP
• Appropriate positive, negative and vehicle controls

Workflow

1Review the lot-matched COA and record identity, purity, batch number and received condition.
2Let the sealed vial equilibrate to room temperature before opening to limit condensation.
3Calculate the target stock concentration with C = mass / volume. Use only a solvent validated for the planned assay.
4Add solvent slowly down the vial wall, mix gently and avoid vortexing unless the validated method permits it.
5Prepare a log-spaced pilot concentration series; determine the usable range empirically instead of assuming a biological dose.
6Run the defined controls and technical replicates alongside every plate or experiment.
7Record preparation time, temperature, equipment, deviations and raw-data file locations.

Assay design

Receptor-activation work is typically a full concentration-response curve in technical triplicate, repeated across at least three independent passages, with all three receptors profiled in parallel so the agonism ratio is measured rather than assumed.

Required controls

Vehicle-only negative control
Matched receptor-null cell line
Validated reference agonist
Untreated viability control

Reported protocol

Initial phase (weeks 1-4): 1.0 mg to 2.0 mg once weekly
Intermediate phase: 4.0 mg once weekly
Target maintenance: 8.0 mg to 12.0 mg once weekly
Route: Subcutaneous

Diluent

Sterile bacteriostatic water (0.9% benzyl alcohol) for multi-withdrawal stock, or sterile water for injection where a preservative-free stock is required by the assay.

Compound-specific: Use bacteriostatic or sterile water only. Sodium-chloride-containing diluents are not a validated solvent for this lipidated, acetate-buffered material and have been associated with cloudiness and precipitation. A vial that goes cloudy on addition of solvent should be discarded, not filtered and used.

Reconstitution concentrations

Solvent volume sets the stock concentration for this 20 mg vial. Lower volume gives a more concentrated stock and smaller working aliquots; higher volume gives a more dilute stock that is easier to measure accurately.

Stock concentration by solvent volume for a 20 mg vial
Solvent added	Stock concentration	Per 0.1 mL	Per unit (U-100)
1 mL	20 mg/mL	2 mg	200 mcg
2 mL	10 mg/mL	1 mg	100 mcg
3 mL	6.67 mg/mL	666.67 mcg	66.67 mcg

Working range

In-vitro receptor pharmacology is normally run as a log-spaced series spanning roughly picomolar to high-nanomolar, because the three receptor arms have materially different potencies. Establish the working range on your own cell line rather than importing a range from a paper that used a different receptor density.

Stability

Lyophilized: Sealed, nitrogen-flushed and stored at the temperature printed on the lot certificate, the lyophilized cake is the stable form. Keep it dry and sealed until the day of use.
In solution: Establish stability empirically for your exact solvent, concentration and container. Lipidated agonists are prone to surface adsorption at low concentration in plain polypropylene.

Handling notes

Let the sealed vial equilibrate to room temperature before opening; opening cold pulls condensation onto the cake.
Add solvent down the vial wall. Do not aim the stream at the cake and do not vortex.
At low working concentrations, use low-binding tubes and tips. Lipidated peptides lose measurable material to plastic.
Profile all three receptor arms in the same run. Comparing a GLP-1R curve from today against a GCGR curve from last month is the most common source of a wrong potency ratio.

Documentation checklist

Record lot and COA, mass balance, solvent and concentration, preparation timestamp, storage history, plate map, replicate plan, instrument settings, exclusions and deviations. Preserve raw data and analysis code with the experiment record.